Effects of resin or charcoal treatment on fetal bovine serum and bovine calf serum

Endocrine Research

Volumn 34, Issue 4, 2009, Pages 101-108

  Cao, Zhimin ^a   West, Clint ^a   Norton Wenzel, Carol S ^a   Rej, Robert ^a,c   Davis, Faith B ^b   Davis, Paul J ^b  

^a WADSWORTH CENTER   (United States)

^b ORDWAY RESEARCH INSTITUTE   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Charcoal stripping of serum; Fetal bovine serum; Fetal calf serum; Resin stripping of Serum

Indexed keywords

ACTIVATED CARBON; CHARCOAL; ELECTROLYTE; ESTRADIOL; HYDROCORTISONE; LIOTHYRONINE; RESIN; TESTOSTERONE; THYROXINE; VITAMIN;

ARTICLE; CONTROLLED STUDY; FETAL CALF SERUM; FETUS; HORMONE DETERMINATION; INTERMETHOD COMPARISON; LABORATORY TEST; METABOLITE; NONHUMAN; PRIORITY JOURNAL; SEROLOGY;

ANIMALS; CATTLE; CELL CULTURE TECHNIQUES; CHARCOAL; CULTURE MEDIA; ELECTROLYTES; ENZYME ACTIVATORS; ENZYMES; HORMONES; RESINS, SYNTHETIC; SERUM; VITAMINS;

EID: 72949103663     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.3109/07435800903204082     Document Type: Article

References (16)

1. Panagiotou S, Hatzoglou A, Calvo F, Martin PM, Castanas E. Modulation of the estrogen-regulated proteins cathepsin D and pS2 by opioid agonists in hormone-sensitive breast cancer cell lines (MCF7 and T47D): evidence for an interaction between the two systems. J Cell Biochem 1998; 71:416-428.
2. Eckert RL, Katzenellenbogen BS. Effect of estrogens and antiestrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells. Cancer Res 1982; 42:139-144.
3. Tso CL, McBride WH, Sun J, et al. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Cancer J 2000; 6(4):220-233.
4. Raffo AJ, Perlman H, Chen MW, et al. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res 1995; 55:4438-4445.
5. Samuels HH, Stanley F, Casanova J. Depletion of L-3,5,3′- triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 1979; 105:80-85.
6. Liby K, Neltner B, Mohamet L, Menchen L, Ben-Jonathan N. Prolactin overexpression by MDA-MB- 435 human breast cancer cells accelerates tumor growth. Breast Cancer Res Treat 2003; 79:241-252.
7. Bahk JY, Hyun JS, Lee H, et al. Expression of gonadotropin-releasing hormone (GnRH) and GnRH receptor mRNA in prostate cancer cells and effect of GnRH on the proliferation of prostate cancer cells. Urol Res 1998; 26:259-264.
8. Cos S, Sanchez-Barcelo EJ. Melatonin inhibition of MCF-7 human breast-cancer cells growth: influence of cell proliferation rate. Cancer Lett 1995; 93:207-212.
9. Uhlenbrock K, Gassenhuber H, Kostenis E. Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors. Cell Signal 2002; 14:941-953.
10. Dang ZC, Lowik CW. Removal of serum factors by charcoal treatment promotes adipogenesis via a MAPK-dependent pathway. Mol Cell Biochem 2005; 268:159-167.
11. Burchardt T, Burchardt M, Chen MW, et al. Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo. J Urol 1999; 162:1800-1805.
12. Lin H-Y, Thacore HR, Davis PJ, Davis FB. Thyroid hormone potentiates the antiviral action of interferon-gamma in cultured human cells. J Clin Endocrinol Metab 1994; 79:62-65.
13. US Department of Health and Human Services. Medicare, Medicaid and CLIA programs: regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA), final rule. Fed Regist 1992; 57:7002-7186.
14. Spink DC, Katz BH, Hussain MM, Pentecost BT, Cao Z, Spink BC. Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells. Carcinogenesis 2003; 24:1941-1950.
15. Vignon F, Rochefort H. Nuclear translocation of the estrogen receptor in autonomous C3H mouse mammary tumors. Cancer Res 1978; 38:1808-1814.
16. Vignon F, Terqui M, Westley B, Derocq D, Rochefort H. Effects of plasma estrogen sulfates in mammary cancer cells. Endocrinology 1980; 106:1079-1086.